SEC Filings | Structure Therapeutics

Filing date	Form	Description	View
Oct 21, 2021	D		View HTML 0001888886-21-000001.pdf 0001888886-21-000001.rtf 0001888886-21-000001.xls
Oct 21, 2021	D		View HTML 0001888886-21-000002.pdf 0001888886-21-000002.rtf 0001888886-21-000002.xls
Oct 21, 2021	D		View HTML 0001888886-21-000003.pdf 0001888886-21-000003.rtf 0001888886-21-000003.xls
Jan 10, 2022	D		View HTML 0001888886-22-000001.pdf 0001888886-22-000001.rtf 0001888886-22-000001.xls
Feb 03, 2023	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001172661-23-000436.pdf 0001172661-23-000436.rtf 0001172661-23-000436.xls
Feb 10, 2023	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000315066-23-002177.pdf 0000315066-23-002177.rtf
Feb 10, 2023	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000318989-23-000055.pdf 0000318989-23-000055.rtf
Feb 13, 2023	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000921895-23-000463.pdf 0000921895-23-000463.rtf 0000921895-23-000463.xls
Jan 30, 2023	S-1/A	Amended Registration statement for face-amount certificate companies	View HTML 0001104659-23-007657.pdf 0001104659-23-007657.rtf 0001104659-23-007657.xls
Nov 16, 2023	10-Q/A	Amendment to a previously filed 10-Q	View HTML 0001558370-23-019165.pdf 0001558370-23-019165.rtf 0001558370-23-019165.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.